22 May 2013
Keywords: triangle, seeks, lift, halt, hiv, drug, pharmaceuticals
Article | 13 June 2000
Triangle Pharmaceuticals has reported data from a Phase I/IIdose-escalation combination study of DMP-450, its cyclic urea-based HIV
protease inhibitor, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
12 June 2000
15 June 2000
21 May 2013
© 2013 thepharmaletter.com